Skip to Content
Learn about Adcetris a treatment of Hodgkin Lymphoma

Drug interactions between Diflucan and Fasigyn

Results for the following 2 drugs:
Diflucan (fluconazole)
Fasigyn (tinidazole)

Interactions between your drugs

There were no interactions found in our database between Diflucan and Fasigyn - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

Diflucan

A total of 711 drugs (3325 brand and generic names) are known to interact with Diflucan.

Fasigyn

A total of 195 drugs (870 brand and generic names) are known to interact with Fasigyn.

Drug and food interactions

Moderate

tinidazole food

Applies to: Fasigyn (tinidazole)

Consumption of alcoholic beverages or products containing alcohol or propylene glycol during treatment with tinidazole may occasionally trigger a reaction in some patients similar to the disulfiram reaction, which includes unpleasant effects such as flushing, throbbing in head and neck, throbbing headache, difficulty breathing, nausea, vomiting, sweating, thirst, chest pain, rapid heartbeat, palpitation, low blood pressure, dizziness, lightheadedness, blurred vision, and confusion. Rarely, more severe reactions may include abnormal heart rhythm, heart attack, heart failure, unconsciousness, convulsions, and even death. Patients treated with tinidazole should avoid using any products containing alcohol or propylene glycol during and for up to 3 days until after completion of therapy. Talk to your doctor or pharmacist if you have questions on how to take this or other medications you are prescribed. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Therapeutic duplication warnings

No therapeutic duplications were found for your selected drugs.

Drug Interaction Classification

The classifications below are a guideline only. The relevance of a particular drug interaction to a specific patient is difficult to determine using this tool alone given the large number of variables that may apply.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide